Evaluating Maternal and Neonatal Health in Rheumatoid Arthritis Pregnancies – Hiroki Ozawa
Hiroki Ozawa, Rheumatologist at St.Luke’s International Hospital, shared a post on LinkedIn about a paper by Yuri Hiramatsu et al. published in Rheumatology:
“Real-World Data from Japan: Treat-to-Target Strategy in RA Pregnancy
Sharing new real-world evidence from the Japanese multicentre ANSWER cohort, which analyzed 118 pregnancies in women with rheumatoid arthritis (RA) and evaluated the impact of a treat-to-target (T2T) approach.
Key Insights from Japan
1․ T2T enables both disease control and healthy pregnancy outcomes
85% of patients maintained remission or low disease activity throughout pregnancy.
Tight control translated into excellent outcomes, including a 92.8% full-term delivery rate.
Continued use of pregnancy-compatible bDMARDs (e.g., etanercept, certolizumab pegol) was linked with lower disease activity during later trimesters.
2․ Salazosulfapyridine (SASP) shows a positive neonatal signal
Maternal SASP use in the third trimester was associated with higher birth weights (P=0.003) and a trend toward longer gestational ages (P=0.051).
While causality needs further confirmation, this real-world signal supports SASP as a potentially beneficial option during pregnancy.
Take-home message:
Individualized T2T strategies are feasible and effective in pregnant RA patients, supporting both maternal stability and optimal fetal health.
Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study | Rheumatology | Oxford Academic
For more research summaries and clinical insights, I share quick audio digests here:
Journal Note — Spotify Podcast”
Title: Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study
Authors: Yuri Hiramatsu, Takuya Kotani, Eri Nakamura, Ayaka Yoshikawa, Motomu Hashimoto, Akira Onishi, Kouichi Murata, Natsuki Yamamoto, Kosaku Murakami, Toru Hirano, Yuichi Maeda, Kosuke Ebina, Sho Sendo, Yonsu Son, Hideki Amuro, Ryota Hara, Masaki Katayama, Wataru Yamamoto, Tohru Takeuchi
Read the full article.

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 19, 2026, 15:24Sims IVF Appoints Leading Reproductive Medicine Specialist Prof. Enda McVeigh as New Medical Director
-
Sep 19, 2026, 15:22Early Fee for ESHRE Campus 2026 Ends 30 September
-
Sep 19, 2026, 15:17Can You Be a Surrogate After 40? – Egg Donor and Surrogate Solutions
-
Sep 19, 2026, 15:14Albert Irkaliev։ Could Pacemaker-Like Cells Influence Embryo Implantation?
-
Sep 19, 2026, 15:11Sheryl Homa։ Delighted to Present at the ARCS Current Practice in Therapeutic Sperm Preparation
-
Sep 19, 2026, 15:07Ángel Martín Bastida: Happy to Have Contributed to This Initiative With a Chapter on Embryonic Mosaicism
-
Sep 19, 2026, 13:33From IVF to Delivery: The Journey Doesn’t End With a Positive Pregnancy Test
-
Sep 18, 2026, 20:27Hrishikesh Pai: Rethinking Male Infertility
-
Sep 18, 2026, 20:25Eric Verdin: Wrapping Up the Reproductive Aging Summit at the Center for Healthy Aging in Women
